Answers are grounded in this paper and cite their sources.
Observational study shows lower survival in hepatocellular carcinoma patients with exercise intolerance, suggesting the need for better management strategies.
Exercise intolerance is associated with lower survival in patients with hepatocellular carcinoma receiving locoregional therapy. In particular, patients with albumin-bilirubin grade 2 and exercise intolerance may be at high risk of poor prognosis after locoregional therapy.
No takes yet. Share an insight, caveat, or question.
Yagi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: